123 related articles for article (PubMed ID: 8631011)
1. Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p53.
Fagin JA; Tang SH; Zeki K; Di Lauro R; Fusco A; Gonsky R
Cancer Res; 1996 Feb; 56(4):765-71. PubMed ID: 8631011
[TBL] [Abstract][Full Text] [Related]
2. A mutated p53 gene alters thyroid cell differentiation.
Battista S; Martelli ML; Fedele M; Chiappetta G; Trapasso F; De Vita G; Battaglia C; Santoro M; Viglietto G; Fagin JA
Oncogene; 1995 Nov; 11(10):2029-37. PubMed ID: 7478522
[TBL] [Abstract][Full Text] [Related]
3. All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.
Kurebayashi J; Tanaka K; Otsuki T; Moriya T; Kunisue H; Uno M; Sonoo H
J Clin Endocrinol Metab; 2000 Aug; 85(8):2889-96. PubMed ID: 10946899
[TBL] [Abstract][Full Text] [Related]
4. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis.
Ros P; Rossi DL; Acebrón A; Santisteban P
Biochimie; 1999 Apr; 81(4):389-96. PubMed ID: 10401674
[TBL] [Abstract][Full Text] [Related]
5. Molecular events in the differentiation of the thyroid gland.
Di Lauro R; Damante G; De Felice M; Arnone MI; Sato K; Lonigro R; Zannini M
J Endocrinol Invest; 1995 Feb; 18(2):117-9. PubMed ID: 7629376
[No Abstract] [Full Text] [Related]
6. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms.
Fabbro D; Di Loreto C; Beltrami CA; Belfiore A; Di Lauro R; Damante G
Cancer Res; 1994 Sep; 54(17):4744-9. PubMed ID: 8062273
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus HSV-TK construct with thyroid-specific promoter: enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the camp pathway.
Kitazono M; Chuman Y; Aikou T; Fojo T
Int J Cancer; 2002 May; 99(3):453-9. PubMed ID: 11992417
[TBL] [Abstract][Full Text] [Related]
8. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
9. Human thyroid cancer cells as a source of iso-genic, iso-phenotypic cell lines with or without functional p53.
Wyllie FS; Haughton MF; Rowson JM; Wynford-Thomas D
Br J Cancer; 1999 Mar; 79(7-8):1111-20. PubMed ID: 10098744
[TBL] [Abstract][Full Text] [Related]
10. Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells.
Xu J; Capezzone M; Xu X; Hershman JM
Mol Endocrinol; 2005 Feb; 19(2):527-39. PubMed ID: 15486044
[TBL] [Abstract][Full Text] [Related]
11. Thyroid peroxidase expression and DNA polymorphisms in thyroid cancer.
Smanik PA; Fithian LJ; Jhiang SM
Biochem Biophys Res Commun; 1994 Feb; 198(3):948-54. PubMed ID: 8117301
[TBL] [Abstract][Full Text] [Related]
12. Functional interaction among thyroid-specific transcription factors: Pax8 regulates the activity of Hex promoter.
Puppin C; Presta I; D'Elia AV; Tell G; Arturi F; Russo D; Filetti S; Damante G
Mol Cell Endocrinol; 2004 Feb; 214(1-2):117-25. PubMed ID: 15062550
[TBL] [Abstract][Full Text] [Related]
13. Pax8 has a key role in thyroid cell differentiation.
Pasca di Magliano M; Di Lauro R; Zannini M
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13144-9. PubMed ID: 11069301
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations in all stages of thyroid carcinomas.
Zou M; Shi Y; Farid NR
J Clin Endocrinol Metab; 1993 Oct; 77(4):1054-8. PubMed ID: 8408453
[TBL] [Abstract][Full Text] [Related]
15. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.
Pocard M; Chevillard S; Villaudy J; Poupon MF; Dutrillaux B; Remvikos Y
Oncogene; 1996 Feb; 12(4):875-82. PubMed ID: 8632910
[TBL] [Abstract][Full Text] [Related]
16. Pax-8 protein levels regulate thyroglobulin gene expression.
Fabbro D; Pellizzari L; Mercuri F; Tell G; Damante G
J Mol Endocrinol; 1998 Dec; 21(3):347-54. PubMed ID: 9845675
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines.
Jossart GH; Epstein HD; Shaver JK; Weier HU; Greulich KM; Tezelman S; Grossman RF; Siperstein AE; Duh QY; Clark OH
J Clin Endocrinol Metab; 1996 Oct; 81(10):3498-504. PubMed ID: 8855792
[TBL] [Abstract][Full Text] [Related]
18. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
Chen J; Lin J; Levine AJ
Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
[TBL] [Abstract][Full Text] [Related]
19. Disturbed expression of type 1 and type 2 iodothyronine deiodinase as well as titf1/nkx2-1 and pax-8 transcription factor genes in papillary thyroid cancer.
Ambroziak M; Pachucki J; Stachlewska-Nasfeter E; Nauman J; Nauman A
Thyroid; 2005 Oct; 15(10):1137-46. PubMed ID: 16279847
[TBL] [Abstract][Full Text] [Related]
20. Regulation of thyroid follicular cell function by intracellular redox-active copper.
Iseki A; Kambe F; Okumura K; Hayakawa T; Seo H
Endocrinology; 2000 Dec; 141(12):4373-82. PubMed ID: 11108245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
